- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00672971
Safety and Efficacy Study to Compare a 4% Dimethicone Foam and Nix Cream Rinse (1% Permethrin) in the Control of Head Lice
May 5, 2008 updated by: Oystershell NV
An Open Label Randomized Study to Compare the Safety and Efficacy of Silcap Plus (Approximately 4% Dimeticone) Against Nix Cream Rinse.
The purpose of this study was to evaluate the efficacy of a dimethicone foam in the control of head lice and to compare the efficacy to a permethrin based product.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
31
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Florida
-
Plantation, Florida, United States, 33313
- Lice Source services Inc
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
4 years to 85 years (Child, Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- 4 - 85 years of age
- active head lice infestation of at least ≥ 10 live lice
- short hair (hair no longer than 2 inches below the neck) or long hair (hair 2 inches below the neck to mid back)
Exclusion Criteria:
- had received or used an investigational new drug within the 30 days immediately preceding the study
- used any form of head lice treatment whether prescription, over-the-counter, or a home remedy for at least fourteen days prior to their study visit
- used topical medication of any kind on the hair for a period of 48 hours prior to the visit
- had a history of allergy to rag weed, permethrin, or mineral oil, or had taken trimethoprim or cotrimoxazole at evaluation or during the previous four weeks
- Female subjects that were pregnant or breast feeding
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: 1
4% dimethicone foam
|
The dimethicone foam is applied to dry hair and left on the hair for approximately 15 minutes.
The product is then removed by washing the hair with baby shampoo.
The foam is applied two time, separated by an interval of 7-9 days.
Other Names:
|
Active Comparator: 2
1% permethrin
|
Nix® Cream Rinse is applied as indicated on the product labeling.
The cream rinse is applied to wet hair and left on the hair for 10 minutes.
The hair is then rinsed with tepid water to remove the product, toweled dry, and combed with a detangling comb.
The product is applied two times, separated by an interval of 7-9 days.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Cure rate at the final visit (Day 14 or 15). Cure rate was defined as the number of subjects free of live head lice divided by the total number of subjects in the treatment group (x 100).
Time Frame: 14 or 15 days after 1st treatment
|
14 or 15 days after 1st treatment
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Any adverse events during or after application of the product
Time Frame: up to 7 or 8 d after product application
|
up to 7 or 8 d after product application
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Lidia Serrano, CRI, Lice Source Services
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
September 1, 2007
Primary Completion (Actual)
November 1, 2007
Study Completion (Actual)
November 1, 2007
Study Registration Dates
First Submitted
May 2, 2008
First Submitted That Met QC Criteria
May 5, 2008
First Posted (Estimate)
May 6, 2008
Study Record Updates
Last Update Posted (Estimate)
May 6, 2008
Last Update Submitted That Met QC Criteria
May 5, 2008
Last Verified
May 1, 2008
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- OYS001-07
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Head Lice
-
Taro Pharmaceuticals USACompletedLice; Head LiceUnited States
-
Topaz Pharmaceuticals IncCompletedPediculus Humanus Capitis (Head Lice)United States
-
Perrigo CSCIRecruiting
-
Dr. Reddy's Laboratories LimitedCompleted
-
Infectopharm Arzneimittel GmbHRecruitingPediculosis Capitis | Head Lice Infestation | LiceGermany
-
Dr. Reddy's Laboratories LimitedTKL Research, Inc.; AccelovanceCompletedHead LiceUnited States
-
Topaz Pharmaceuticals IncCompleted
-
Dr. Reddy's Laboratories LimitedSyneos Health; AccelovanceCompletedHead Lice InfestationUnited States
-
Alliance PharmaceuticalsSouth Florida Family Health and Research CentersRecruitingHead Lice | Lice Infestations | Pediculosis CapitisUnited States
-
Perrigo CSCIRecruitingHead Lice InfestationMauritius
Clinical Trials on 4% dimethicone foam
-
Mylan Inc.Vyne Therapeutics Inc.; DPT Laboratories, Ltd.CompletedScabiesUnited States, Dominican Republic, Honduras, Puerto Rico
-
Vyne Therapeutics Inc.CompletedAcne VulgarisUnited States, Dominican Republic
-
Vyne Therapeutics Inc.CompletedAcne VulgarisUnited States, Dominican Republic
-
Vyne Therapeutics Inc.Completed
-
John FowlerAvadim Technologies, Inc.Withdrawn
-
Therapeutics, Inc.CompletedPlaque PsoriasisUnited States
-
Therapeutics, Inc.CompletedPlaque PsoriasisUnited States
-
Therapeutics, Inc.CompletedPlaque PsoriasisUnited States
-
Daniel Muñoz-GarciaCamilo Jose Cela UniversityCompleted
-
Arcutis Biotherapeutics, Inc.CompletedSeborrheic DermatitisUnited States, Canada